High vitamin B12 levels are seen in ~50% of the patients with hepatocellular carcinoma [97] and in patients with liver metastases [98], with a possible underlying mechanism of decreased cobalamin–haptocorrin clearance and cobalamin release during hepatic cytolysis caused by cancer cells [99]. The gene discussed is TCN1; the disease is cancer.